{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:08:26Z","timestamp":1788815306839,"version":"build-2803163510"},"reference-count":219,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007281","name":"National Drug and Alcohol Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003921","name":"Department of Health, Disability and Ageing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2016825"],"award-info":[{"award-number":["2016825"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.psychres.2026.117380","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:20:03Z","timestamp":1786429203000},"page":"117380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cannabis and cannabinoids for the treatment of mental and substance use disorders and symptoms: A systematic review and meta-analysis of experimental and observational studies"],"prefix":"10.1016","volume":"365","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9778-0386","authenticated-orcid":false,"given":"Chrianna","family":"Bharat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9775-9057","authenticated-orcid":false,"given":"Xintong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvert","family":"Tisdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4503-8488","authenticated-orcid":false,"given":"Sophia","family":"Glasgow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0380-3773","authenticated-orcid":false,"given":"Zoe","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Thomas","family":"Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7611-6292","authenticated-orcid":false,"given":"Swara","family":"Kale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0046","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000521492","article-title":"Medicinal cannabis for the treatment of chronic refractory pain: an investigation of the adverse event profile and health-related quality of life impact of an oral formulation","volume":"5","author":"Abelev","year":"2022","journal-title":"Med. cannabis cannabinoids"},{"issue":"7","key":"10.1016\/j.psychres.2026.117380_bib0047","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1212\/01.wnl.0000253187.66183.9c","article-title":"Cannabis in painful HIV-associated sensory neuropathy","volume":"68","author":"Abrams","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.psychres.2026.117380_bib0026","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamapsychiatry.2013.3947","article-title":"Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial","volume":"71","author":"Allsop","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0048","first-page":"e338","article-title":"Impact of medical cannabis on patient-reported symptoms for patients with cancer enrolled in minnesota's medical cannabis program","volume":"15","author":"Anderson","year":"2019","journal-title":"J. oncol. pr.\/Am. Soc. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0018","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00213-019-05442-6","article-title":"Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis","volume":"237","author":"Appiah-Kusi","year":"2020","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0032","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/WNF.0b013e3181633497","article-title":"Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study","volume":"32","author":"Aragona","year":"2009","journal-title":"Clin. Neuropharmacol."},{"issue":"12","key":"10.1016\/j.psychres.2026.117380_bib0049","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/ph13120435","article-title":"Short-term medical cannabis treatment regimens produced beneficial effects among palliative cancer patients","volume":"13","author":"Aviram","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.psychres.2026.117380_bib0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jad.2018.05.065","article-title":"Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization","volume":"241","author":"Bahorik","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2026.117380_bib0142","first-page":"S18","article-title":"Cbd in patients with low back pain caused by lumbar spinal stenosis: An observational study","volume":"13","author":"Bakewell","year":"2021","journal-title":"PM R"},{"issue":"6","key":"10.1016\/j.psychres.2026.117380_bib0143","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/WNF.0000000000000246","article-title":"Medical cannabis in parkinson disease: real-life patients' experience","volume":"40","author":"Balash","year":"2017","journal-title":"Clin. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0012","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"BMJ Ment. Health"},{"issue":"-12","key":"10.1016\/j.psychres.2026.117380_bib0144","article-title":"The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis","author":"Ball","year":"2015","journal-title":"Health technol. assess. (Winch. Engl.)"},{"key":"10.1016\/j.psychres.2026.117380_bib0145","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.827849","article-title":"Adherence, safety, and effectiveness of medical cannabis and epidemiological characteristics of the patient population: a prospective study","volume":"9","author":"Bar-Lev Schleider","year":"2022","journal-title":"Front. med."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0212","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/can.2022.0112","article-title":"Use of medical cannabis in patients with Gilles de la Tourette's syndrome in a real-world setting","volume":"9","author":"Barchel","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"issue":"12","key":"10.1016\/j.psychres.2026.117380_bib0201","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.cgh.2019.01.018","article-title":"Effects of medical cannabis on use of opioids and hospital visits by patients with painful chronic pancreatitis","volume":"17","author":"Barlowe","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0203","first-page":"E113","article-title":"Medical Cannabis used as an alternative treatment for chronic pain demonstrates reduction in chronic opioid use - a prospective study","volume":"25","author":"Benedict","year":"2022","journal-title":"Pain Physician"},{"issue":"6","key":"10.1016\/j.psychres.2026.117380_bib0019","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0051","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1533-2500.2010.00427.x","article-title":"An open-label comparison of nabilone and gabapentin as adjuvant therapy or monotherapy in the management of neuropathic pain in patients with peripheral neuropathy","volume":"11","author":"Bestard","year":"2011","journal-title":"Pain Pr."},{"issue":"suppl_1","key":"10.1016\/j.psychres.2026.117380_bib0183","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/schbul\/sby014.067","article-title":"17.3 Effect of cannabidiol on symptoms, distress and neurophysiological abnormalities in clinical high-risk for psychosis patients: a placebo-controlled study","volume":"44","author":"Bhattacharyya","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2026.117380_bib0204","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugalcdep.2015.05.013","article-title":"The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone","volume":"154","author":"Bisaga","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"12","key":"10.1016\/j.psychres.2026.117380_bib0004","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S2215-0366(19)30401-8","article-title":"Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis","volume":"6","author":"Black","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2026.117380_bib0198","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jpain.2016.03.002","article-title":"Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain","volume":"17","author":"Boehnke","year":"2016","journal-title":"J. Pain"},{"issue":"7","key":"10.1016\/j.psychres.2026.117380_bib0184","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00213-018-4885-9","article-title":"The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial","volume":"235","author":"Boggs","year":"2018","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.psychres.2026.117380_bib0053","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1590\/1516-4446-2021-2317","article-title":"The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event","volume":"44","author":"Bolsoni","year":"2022","journal-title":"Rev. bras. psiquiatr. (Sao Paulo Braz."},{"issue":"5","key":"10.1016\/j.psychres.2026.117380_bib0054","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00213-021-06043-y","article-title":"Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder","volume":"239","author":"Bolsoni","year":"2022","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.psychres.2026.117380_bib0176","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/schbul\/sbae097","article-title":"Randomized laboratory study of single-dose cannabis, dronabinol, and placebo in patients with schizophrenia and cannabis use disorder","volume":"51","author":"Brunette","year":"2025","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.psychres.2026.117380_bib0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.34354","article-title":"Year-long cannabis use for medical symptoms and brain activation during cognitive processes","volume":"7","author":"Burdinski","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.psychres.2026.117380_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.626853","article-title":"Evaluation of patient reported safety and efficacy of cannabis from a survey of medical cannabis patients in Canada","volume":"9","author":"Cahill","year":"2021","journal-title":"Front. Public Health"},{"issue":"5","key":"10.1016\/j.psychres.2026.117380_bib0193","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/JCP.0000000000000180","article-title":"Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder\u2013related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation","volume":"34","author":"Cameron","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2026.117380_bib0057","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2023.1279123","article-title":"Cannabis use in the UK: a quantitative comparison of individual differences in medical and recreational cannabis users","volume":"14","author":"Ciesluk","year":"2024","journal-title":"Front. Psychol."},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0052","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1089\/can.2023.0187","article-title":"Acute and extended anxiolytic effects of cannabidiol in cannabis flower: a quasi-experimental ad libitum use study","volume":"9","author":"Cinnamon Bidwell","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"issue":"6","key":"10.1016\/j.psychres.2026.117380_bib0001","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jamapsychiatry.2017.0723","article-title":"Medical marijuana laws and cannabis use: intersections of health and policy","volume":"74","author":"Compton","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2026.117380_bib0058","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1083334","article-title":"Development of cannabis use disorder in medical cannabis users: a 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership","volume":"14","author":"Cooke","year":"2023","journal-title":"Front. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2026.117380_bib0213","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.euroneuro.2017.05.005","article-title":"Cannabinoids in attention-deficit\/hyperactivity disorder: a randomised-controlled trial","volume":"27","author":"Cooper","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0059","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70490","article-title":"UK medical cannabis registry: a clinical outcomes analysis for epilepsy","volume":"15","author":"Cowley","year":"2025","journal-title":"Brain Behav."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0033","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0146","first-page":"232","article-title":"Therapeutic value of medical marijuana in new jersey patients: a community partnership research endeavor","volume":"46","author":"Crowell","year":"2017","journal-title":"J. Allied Health"},{"key":"10.1016\/j.psychres.2026.117380_bib0060","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jad.2018.04.054","article-title":"A naturalistic examination of the perceived effects of cannabis on negative affect","volume":"235","author":"Cuttler","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.psychres.2026.117380_bib0187","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","article-title":"Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction","volume":"57","author":"D\u2019Souza","year":"2005","journal-title":"Biol. psychiatry (1969)"},{"issue":"5","key":"10.1016\/j.psychres.2026.117380_bib0061","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/14737175.2025.2490539","article-title":"UK medical cannabis registry: an updated clinical outcomes analysis of patients with post-traumatic stress disorder","volume":"25","author":"Datta","year":"2025","journal-title":"Expert Rev. Neurother."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0062","article-title":"UK medical cannabis registry: A clinical outcome analysis of medical cannabis therapy in chronic pain patients with and without co-morbid sleep impairment","volume":"25","author":"Datta","year":"2025","journal-title":"Pain Pr."},{"issue":"12","key":"10.1016\/j.psychres.2026.117380_bib0027","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.joen.2024.10.010","article-title":"Effect of preoperative oral cannabidiol-rich cannabis extract on anxiety and postoperative pain after endodontic treatment: a double-blind randomized clinical trial","volume":"50","author":"de Andrade Silva","year":"2024","journal-title":"J. Endod."},{"issue":"5","key":"10.1016\/j.psychres.2026.117380_bib0039","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1590\/1516-4446-2020-1416","article-title":"Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study","volume":"43","author":"de Meneses-Gaya","year":"2021","journal-title":"Braz. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2026.117380_bib0063","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cgh.2016.09.147","article-title":"Tetrahydrocannabinol does not reduce pain in patients with chronic abdominal pain in a phase 2 placebo-controlled study","volume":"15","author":"de Vries","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.psychres.2026.117380_bib0217","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115318","article-title":"Meta-review on the efficacy of psychological therapies for the treatment of substance use disorders","volume":"326","author":"Dellazizzo","year":"2023","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2026.117380_bib0064","article-title":"Anxiety severity and prescription medication utilization in first-time medical marijuana users","volume":"14","author":"Dugosh","year":"2023","journal-title":"J. Affect. Disord. Rep."},{"key":"10.1016\/j.psychres.2026.117380_bib0025","doi-asserted-by":"crossref","DOI":"10.1089\/can.2024.0028","article-title":"Chronic cannabidiol administration mitigates excessive daytime sleepiness and fatigue in patients with primary hypertension: insights from a randomized crossover trial","author":"Dujic","year":"2024","journal-title":"Cannabis cannabinoid res."},{"key":"10.1016\/j.psychres.2026.117380_bib0147","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.116055","article-title":"Effects of medical cannabis use on physical and psychiatric symptoms across the day among older adults","volume":"339","author":"Dvorak","year":"2024","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.psychres.2026.117380_bib0148","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/npp.2008.120","article-title":"Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial","volume":"34","author":"Ellis","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0065","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/17512433.2022.2020640","article-title":"UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder","volume":"15","author":"Ergisi","year":"2022","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2026.117380_bib0066","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/npr2.12183","article-title":"An initial analysis of the UK medical cannabis registry: outcomes analysis of first 129 patients","volume":"41","author":"Erridge","year":"2021","journal-title":"Neuropsychopharmacol. Rep."},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0067","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/npr2.12403","article-title":"An observational study of clinical outcome measures in patients treated with cannabis-based medicinal products on the UK Medical Cannabis Registry","volume":"43","author":"Erridge","year":"2023","journal-title":"Neuropsychopharmacol. Rep."},{"issue":"S1","key":"10.1016\/j.psychres.2026.117380_bib0068","doi-asserted-by":"crossref","first-page":"377S","DOI":"10.1002\/j.1552-4604.1981.tb02617.x","article-title":"The efficacy and safety of nabilone (A Synthetic Cannabinoid) in the treatment of anxiety","volume":"21","author":"Fabre","year":"1981","journal-title":"J. clin. pharmacol."},{"key":"10.1016\/j.psychres.2026.117380_bib0149","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2020.110130","article-title":"Depression level, not pain severity, is associated with smoked medical marijuana dosage among chronic pain patients","volume":"135","author":"Feingold","year":"2020","journal-title":"J. Psychosom. Res."},{"issue":"6","key":"10.1016\/j.psychres.2026.117380_bib0069","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1037\/pha0000709","article-title":"Examination of the effects of cannabidiol on menstrual-related symptoms","volume":"32","author":"Ferretti","year":"2024","journal-title":"Exp. clin. psychopharmacol."},{"key":"10.1016\/j.psychres.2026.117380_bib0070","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1196160","article-title":"Patients' perspectives on prescription cannabinoid therapies: a cross-sectional, exploratory, anonymous, one-time web-based survey among German patients","volume":"10","author":"Fischer","year":"2023","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.psychres.2026.117380_bib0071","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/15360288.2024.2340076","article-title":"Assessment of clinical outcomes in patients with osteoarthritis: analysis from the UK medical cannabis registry","volume":"38","author":"Francis","year":"2024","journal-title":"J. Pain Palliat. Care Pharmacother."},{"issue":"7637","key":"10.1016\/j.psychres.2026.117380_bib0072","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.39429.619653.80","article-title":"Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study","volume":"336","author":"Frank","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0195","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1755-5949.2008.00071.x","article-title":"The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD)","volume":"15","author":"Fraser","year":"2009","journal-title":"CNS neurosci. ther."},{"issue":"10","key":"10.1016\/j.psychres.2026.117380_bib0040","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S2215-0366(20)30290-X","article-title":"Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial","volume":"7","author":"Freeman","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117380_bib0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.2106","article-title":"Effect of medical marijuana card ownership on pain, insomnia, and affective disorder symptoms in adults: a randomized clinical trial","volume":"5","author":"Gilman","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"Supplement 2","key":"10.1016\/j.psychres.2026.117380_bib0150","first-page":"S447","article-title":"Long-term safety of medical cannabis in parkinson's disease: a retrospective case-control study","volume":"37","author":"Goldberg","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.psychres.2026.117380_bib0041","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00213-023-06437-0","article-title":"The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial","volume":"240","author":"Gournay","year":"2023","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.psychres.2026.117380_bib0190","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/jts.23072","article-title":"The effects of acute versus repeated cannabidiol administration on trauma-relevant emotional reactivity: A double-blind, randomized, placebo-controlled trial","volume":"37","author":"Gournay","year":"2024","journal-title":"J. trauma. stress"},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0194","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/02791072.2013.873843","article-title":"PTSD symptom reports of patients evaluated for the new mexico medical cannabis program","volume":"46","author":"Greer","year":"2014","journal-title":"J. Psychoact. Drugs"},{"issue":"2","key":"10.1016\/j.psychres.2026.117380_bib0073","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1037\/pha0000435","article-title":"No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms","volume":"29","author":"Gruber","year":"2021","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2026.117380_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102830","article-title":"Patterns of medical cannabis use among patients diagnosed with multiple sclerosis","volume":"50","author":"Guarnaccia","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0074","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen20X101010","article-title":"Cannabidiol prescription in clinical practice: An audit on the first 400 patients in New Zealand","volume":"4","author":"Gulbransen","year":"2020","journal-title":"BJGP Open"},{"key":"10.1016\/j.psychres.2026.117380_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104073","article-title":"Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150mg\/mL) versus placebo in mild to moderate anxiety subjects: a double blind multicenter randomized clinical trial","volume":"97","author":"Gundugurti","year":"2024","journal-title":"Asian J. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2026.117380_bib0075","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/17474124.2024.2443574","article-title":"UK medical cannabis registry: an updated analysis of clinical outcomes of cannabis-based medicinal products for inflammatory bowel disease","volume":"18","author":"Gupta","year":"2024","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0182","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1590\/S1516-44462010000100011","article-title":"Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)","volume":"32","author":"Hallak","year":"2010","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0076","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/15360288.2024.2414898","article-title":"Changes in pain and mental health symptoms associated with prescribed medicinal cannabis use: a one-year longitudinal study","volume":"39","author":"Halman","year":"2025","journal-title":"J. Pain Palliat. Care Pharmacother."},{"issue":"8","key":"10.1016\/j.psychres.2026.117380_bib0005","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3390\/ph16081079","article-title":"Cannabis-based medicine for neuropathic pain and spasticity-a multicenter, randomized, double-blinded, placebo-controlled trial","volume":"16","author":"Hansen","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.psychres.2026.117380_bib0021","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1200\/JCO.22.01632","article-title":"Phase IIb randomized, placebo-controlled, dose-escalating, double-blind study of cannabidiol oil for the relief of symptoms in advanced cancer (MedCan1-CBD)","volume":"41","author":"Hardy","year":"2023","journal-title":"J. clin. oncol."},{"key":"10.1016\/j.psychres.2026.117380_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J. Biomed. Inf."},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0077","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/17512433.2022.2017771","article-title":"UK Medical Cannabis registry: an analysis of clinical outcomes of medicinal cannabis therapy for chronic pain conditions","volume":"15","author":"Harris","year":"2022","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0017","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/adb.12664","article-title":"Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse","volume":"24","author":"Herrmann","year":"2019","journal-title":"Addctn. Biol."},{"issue":"2","key":"10.1016\/j.psychres.2026.117380_bib0151","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ejp.2054","article-title":"Safety and effectiveness of cannabinoids to Danish patients with treatment refractory chronic pain-A retrospective observational real-world study","volume":"27","author":"Horsted","year":"2023","journal-title":"Eur. J. Pain (U. K.)"},{"key":"10.1016\/j.psychres.2026.117380_bib0003","article-title":"Therapeutic use of cannabis and cannabinoids: a review","author":"Hsu","year":"2025","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0219","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jama.2025.19433","article-title":"Therapeutic use of cannabis and cannabinoids: a review","volume":"335","author":"Hsu","year":"2026","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0078","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41398-023-02410-9","article-title":"Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder","volume":"13","author":"Hua","year":"2023","journal-title":"Transl Psychiatry Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117380_bib0079","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/0269881117737400","article-title":"The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group","volume":"32","author":"Hundal","year":"2018","journal-title":"J. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.psychres.2026.117380_bib0042","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/appi.ajp.2019.18101191","article-title":"Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: a double-blind randomized placebo-controlled trial","volume":"176","author":"Hurd","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0080","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/npr2.12400","article-title":"UK medical cannabis registry: an analysis of clinical outcomes of medicinal cannabis therapy for attention-deficit\/hyperactivity disorder","volume":"43","author":"Ittiphakorn","year":"2023","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.psychres.2026.117380_bib0191","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","article-title":"The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: a preliminary randomized, double-blind, placebo-controlled cross-over design study","volume":"51","author":"Jetly","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.psychres.2026.117380_bib0081","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1089\/can.2020.0140","article-title":"Authorization patterns, safety, and effectiveness of medical cannabis in Quebec","volume":"6","author":"Kalaba","year":"2021","journal-title":"Cannabis Cannabinoid Res."},{"issue":"10","key":"10.1016\/j.psychres.2026.117380_bib0082","first-page":"7863","article-title":"Sex differences exist in the perceived relief of cancer symptoms with medical cannabis: results from the quebec cannabis registry","volume":"30","author":"Kasvis","year":"2022","journal-title":"Support. Care Cancer"},{"issue":"12","key":"10.1016\/j.psychres.2026.117380_bib0083","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/jcph.1961","article-title":"Clinical outcome data of first cohort of chronic pain patients treated with cannabis-based sublingual oils in the United Kingdom: analysis from the UK medical cannabis registry","volume":"61","author":"Kawka","year":"2021","journal-title":"J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2026.117380_bib0084","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1007\/s10620-018-5040-5","article-title":"Profiles of patients who use marijuana for inflammatory bowel disease","volume":"63","author":"Kerlin","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.psychres.2026.117380_bib0152","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.736822","article-title":"Cannabidiol cigarettes as adjunctive treatment for psychotic disorders - a randomized, open-label pilot-study","volume":"12","author":"Kock","year":"2021","journal-title":"Front. psychiatry"},{"key":"10.1016\/j.psychres.2026.117380_bib0022","article-title":"Rest assured: a melatonin-free supplement improves sleep, associated health outcomes, and overall well-being in a randomized, double-blind, placebo-controlled trial","volume":"06","author":"Kolobaric","year":"2023","journal-title":"medRxiv"},{"issue":"8","key":"10.1016\/j.psychres.2026.117380_bib0029","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3390\/ph17080977","article-title":"A randomized, double-blind, placebo-controlled trial to assess the effectiveness and safety of melatonin and three formulations of floraworks proprietary TruCBN™ for improving sleep","volume":"17","author":"Kolobaric","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.psychres.2026.117380_bib0002","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.socscimed.2019.06.005","article-title":"Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: systematic review and meta-analysis","volume":"233","author":"Kosiba","year":"2019","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.psychres.2026.117380_bib0085","article-title":"Medical cannabis and cannabis-based medicine show both potential efficacy and potential harms: Cross-sectional comparison with controls on self-rated and interviewer-rated outcomes within the Danish pilot program on medical cannabis","volume":"45","author":"Kudahl","year":"2021","journal-title":"Complement. Ther. Clin. Pr."},{"key":"10.1016\/j.psychres.2026.117380_bib0086","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-022-03948-6","article-title":"An investigation of cannabis use for insomnia in depression and anxiety in a naturalistic sample","volume":"22","author":"Kuhathasan","year":"2022","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2026.117380_bib0087","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.euroneuro.2022.04.003","article-title":"Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial","volume":"59","author":"Kwee","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0088","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00213-023-06512-6","article-title":"Effects of cannabidiol on fear conditioning in anxiety disorders: decreased threat expectation during retention, but no enhanced fear re-extinction","volume":"241","author":"Kwee","year":"2024","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.psychres.2026.117380_bib0034","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1007\/s00415-016-8145-9","article-title":"A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington\u2019s disease","volume":"263","author":"L\u00f3pez-Send\u00f3n Moreno","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.psychres.2026.117380_bib0089","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jad.2020.05.132","article-title":"Short and long-term effects of cannabis on symptoms of post-traumatic stress disorder","volume":"274","author":"LaFrance","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2026.117380_bib0153","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.110032","article-title":"Psychiatric comorbidities before and after cannabidiol treatment in adult patients with drug resistant focal epilepsy","volume":"160","author":"Lamonarca","year":"2024","journal-title":"Epilepsy Behav."},{"issue":"6","key":"10.1016\/j.psychres.2026.117380_bib0090","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/07067437211043393","article-title":"Generalized anxiety disorder 7-item (GAD-7) scores in medically authorized cannabis patients-ontario and Alberta, Canada","volume":"67","author":"Lee","year":"2022","journal-title":"Can. J. Psychiatry - Rev. Can. Psychiatr."},{"issue":"10","key":"10.1016\/j.psychres.2026.117380_bib0188","first-page":"1243","article-title":"Risk of psychotic disorders among patients with medical cannabis authorization: a longitudinal cohort study","volume":"45","author":"Lee","year":"2022","journal-title":"Drug Saf."},{"key":"10.1016\/j.psychres.2026.117380_bib0091","article-title":"A double-blind, randomized, placebo-controlled test of the effects of cannabidiol on fear elicited by a 10% carbon dioxide-enriched air breathing challenge","author":"Leen-Feldner","year":"2022","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0216","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/wps.20941","article-title":"The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses","volume":"21","author":"Leichsenring","year":"2022","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0154","doi-asserted-by":"crossref","DOI":"10.1186\/s42238-024-00245-9","article-title":"Changes in health-related quality of life over the first three months of medical marijuana use","volume":"6","author":"Lent","year":"2024","journal-title":"J. Cannabis Res."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0173","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2010.12.010","article-title":"Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial","volume":"116","author":"Levin","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.psychres.2026.117380_bib0174","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.drugalcdep.2015.11.025","article-title":"Dronabinol and lofexidine for cannabis use disorder: a randomized, double-blind, placebo-controlled trial","volume":"159","author":"Levin","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.psychres.2026.117380_bib0177","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108765","article-title":"Non-abstinent treatment outcomes for cannabis use disorder","volume":"225","author":"Levin","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.psychres.2026.117380_bib0185","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117380_bib0189","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.614811","article-title":"Cannabidiol and amisulpride improve cognition in acute schizophrenia in an explorative, double-blind, active-controlled, randomized clinical trial","volume":"12","author":"Leweke","year":"2021","journal-title":"Front. pharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2026.117380_bib0155","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/dar.12964","article-title":"Medical and non-medical cannabis use and risk of prescription opioid use disorder: findings from propensity score matching","volume":"38","author":"Liang","year":"2019","journal-title":"Drug Alcohol Rev."},{"issue":"5","key":"10.1016\/j.psychres.2026.117380_bib0156","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5694\/mja17.01247","article-title":"Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS-16)","volume":"209","author":"Lintzeris","year":"2018","journal-title":"Med. J. Aust."},{"issue":"9","key":"10.1016\/j.psychres.2026.117380_bib0172","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jamainternmed.2019.1993","article-title":"Nabiximols for the treatment of cannabis dependence: a randomized clinical trial","volume":"179","author":"Lintzeris","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.psychres.2026.117380_bib0178","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108220","article-title":"Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial","volume":"215","author":"Lintzeris","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0214","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00406-018-0970-7","article-title":"Cannabis and mental illness: a review","volume":"269","author":"Lowe","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2026.117380_bib0197","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-019-0278-6","article-title":"Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; Results from a cross-sectional survey of authorized patients","volume":"16","author":"Lucas","year":"2019","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.psychres.2026.117380_bib0209","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102963","article-title":"Reductions in alcohol use following medical cannabis initiation: Results from a large cross-sectional survey of medical cannabis patients in Canada","volume":"86","author":"Lucas","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.psychres.2026.117380_bib0206","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108481","article-title":"Self-reported reductions in tobacco and nicotine use following medical cannabis initiation: Results from a cross-sectional survey of authorized medical cannabis patients in Canada","volume":"130","author":"Lucas","year":"2021","journal-title":"J. Subst. Abuse Treat."},{"issue":"2","key":"10.1016\/j.psychres.2026.117380_bib0157","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2024.13","article-title":"Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidence","volume":"10","author":"Lynskey","year":"2024","journal-title":"BJPsych Open"},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-2001-15191","article-title":"Influence of treatment of tourette syndrome with \u03949-tetrahydrocannabinol (\u03949-THC) on neuropsychological performance","volume":"34","author":"M\u00fcller-Vahl","year":"2001","journal-title":"Pharmacopsychiatry"},{"issue":"9","key":"10.1016\/j.psychres.2026.117380_bib0092","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/COC.0000000000000718","article-title":"Medical cannabis in cancer patients: a survey of a community hematology oncology population","volume":"43","author":"Macari","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.psychres.2026.117380_bib0093","first-page":"n\/a-n\/a","article-title":"Dronabinol increases pain threshold in patients with functional chest pain: a pilot double-blind placebo-controlled trial: dronabinol increases pain threshold in patients","author":"Malik","year":"2016","journal-title":"Dis. Esophagus"},{"issue":"11-12","key":"10.1016\/j.psychres.2026.117380_bib0094","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/14737175.2022.2161894","article-title":"Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK medical cannabis registry","volume":"22","author":"Mangoo","year":"2022","journal-title":"Expert Rev. Neurother."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0158","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2008.06.037","article-title":"Cannabis use in Spanish patients with multiple sclerosis: Fulfilment of patients' expectations?","volume":"273","author":"Mart\u00ednez-Rodr\u00edguez","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.psychres.2026.117380_bib0095","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.729800","article-title":"Antidepressant and anxiolytic effects of medicinal cannabis use in an observational trial","volume":"12","author":"Martin","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2026.117380_bib0096","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3390\/ph17101335","article-title":"The Interplay of Exogenous Cannabinoid Use on Anandamide and 2-Arachidonoylglycerol in Anxiety: Results from a Quasi-Experimental Ad Libitum Study","volume":"17","author":"Martin-Willett","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0097","doi-asserted-by":"crossref","DOI":"10.1186\/s42238-021-00060-6","article-title":"Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series","volume":"3","author":"Mazza","year":"2021","journal-title":"J. Cannabis Res."},{"issue":"3","key":"10.1016\/j.psychres.2026.117380_bib0181","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2018","journal-title":"Am. j. psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2026.117380_bib0192","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3138\/jmvfh-2019-0028","article-title":"Use of a synthetic cannabinoid (nabilone) in the ongoing management of posttraumatic stress disorder nightmares in the Canadian Armed Forces: Results of an anonymous online survey","volume":"6","author":"Meakin","year":"2020","journal-title":"J. Mil. Veteran Fam. Health"},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0179","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13011-022-00493-z","article-title":"Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder","volume":"17","author":"Mills","year":"2022","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0211","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/can.2018.0050","article-title":"Treatment of gilles de la tourette syndrome with cannabis-based medicine: results from a retrospective analysis and online survey","volume":"4","author":"Milosev","year":"2019","journal-title":"Cannabis Cannabinoid Res."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0098","doi-asserted-by":"crossref","DOI":"10.1186\/s42238-023-00192-x","article-title":"Naturalistic examination of the anxiolytic effects of medical cannabis and associated gender and age differences in a Canadian cohort","volume":"5","author":"Minhas","year":"2023","journal-title":"J. Cannabis Res."},{"key":"10.1016\/j.psychres.2026.117380_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2025.107841","article-title":"Cannabidiol and cognitive functions\/inflammatory markers in Parkinson's disease: a double-blind randomized controlled trial at Buriram Hospital (CBD-PD-BRH trial)","volume":"135","author":"Mitarnun","year":"2025","journal-title":"Park. relat. disord."},{"issue":"5","key":"10.1016\/j.psychres.2026.117380_bib0043","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/ADM.0000000000000959","article-title":"Cannabidiol effect on anxiety symptoms and stress response in individuals with cocaine use disorder: exploratory results from a randomized controlled trial","volume":"16","author":"Mongeau-Perusse","year":"2022","journal-title":"J. Addctn. Med."},{"key":"10.1016\/j.psychres.2026.117380_bib0099","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109388","article-title":"Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial","volume":"234","author":"Montebello","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.psychres.2026.117380_bib0208","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2025.1516351","article-title":"A preliminary randomized trial of the safety, tolerability, and clinical effects of hemp-derived cannabidiol in alcohol use disorder","volume":"16","author":"Mueller","year":"2025","journal-title":"Front. psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0100","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4088\/JCP.v64n0417","article-title":"Delta 9-Tetrahydrocannabinol (THC) is effective in the treatment of tics in tourette syndrome: a 6-week randomized trial","volume":"64","author":"Muller-Vahl","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117380_bib0101","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115135","article-title":"CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study","volume":"323","author":"Muller-Vahl","year":"2023","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.psychres.2026.117380_bib0210","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/can.2023.0114","article-title":"The effect of nabiximols on driving ability in adults with chronic tic disorders: results of a substudy analysis of the double-blind, randomized, placebo-controlled CANNA-TICS trial","volume":"9","author":"Muller-Vahl","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0102","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/npr2.12407","article-title":"A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance","volume":"44","author":"Murphy","year":"2024","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.psychres.2026.117380_bib0103","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105665","article-title":"Clinical outcome analysis of patients with multiple sclerosis - Analysis from the UK Medical Cannabis Registry","volume":"87","author":"Murphy","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.psychres.2026.117380_bib0159","doi-asserted-by":"crossref","unstructured":"Myers B, Geist T, Hart P, et al. Medical cannabis in the treatment of parkinson's disease. Neurology; Vol. 92(15): 2019-05.","DOI":"10.1212\/WNL.92.15_supplement.P2.8-016"},{"issue":"3","key":"10.1016\/j.psychres.2026.117380_bib0104","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jpain.2007.10.018","article-title":"Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy","volume":"9","author":"Narang","year":"2008","journal-title":"J. Pain"},{"issue":"5","key":"10.1016\/j.psychres.2026.117380_bib0031","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5664\/jcsm.10998","article-title":"Cannabidiol for moderate-severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing","volume":"20","author":"Narayan","year":"2024","journal-title":"J. clin. sleep med."},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/10499091221110217","article-title":"Assessing efficacy and use patterns of medical cannabis for symptom management in elderly cancer patients","volume":"40","author":"Nathan","year":"2023","journal-title":"Am. J. Hosp. Palliat. Med."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0186","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000541364","article-title":"Treatment of neuropsychiatric symptoms in alzheimer's disease with a cannabis-based magistral formulation: an open-label prospective cohort study","volume":"7","author":"Navarro","year":"2024","journal-title":"Med. Cannabis Cannabinoids"},{"issue":"12","key":"10.1016\/j.psychres.2026.117380_bib0106","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.50391","article-title":"Cannabidiol for scan-related anxiety in women with advanced breast cancer: a randomized clinical trial","volume":"7","author":"Nayak","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0007","article-title":"Le Foll B. Pharmacotherapies for cannabis dependence","author":"Nielsen","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.psychres.2026.117380_bib0107","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2044.2004.03674.x","article-title":"Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 \u2018N of 1\u2019 studies","volume":"59","author":"Notcutt","year":"2004","journal-title":"Anaesthesia"},{"issue":"9","key":"10.1016\/j.psychres.2026.117380_bib0160","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1468-1331.2010.03328.x","article-title":"A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex\u00ae), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis","volume":"18","author":"Novotna","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.psychres.2026.117380_bib0108","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.genhosppsych.2017.11.001","article-title":"Patterns and correlates of medical cannabis use for pain among patients prescribed long-term opioid therapy","volume":"50","author":"Nugent","year":"2018","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117380_bib0109","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/17512433.2023.2183841","article-title":"An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry","volume":"16","author":"Olsson","year":"2023","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.psychres.2026.117380_bib0009","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"11-12","key":"10.1016\/j.psychres.2026.117380_bib0110","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1080\/14737175.2022.2155139","article-title":"Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK medical cannabis registry","volume":"22","author":"Pillai","year":"2022","journal-title":"Expert Rev. Neurother."},{"issue":"8","key":"10.1016\/j.psychres.2026.117380_bib0036","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10194-012-0490-1","article-title":"Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial","volume":"13","author":"Pini","year":"2012","journal-title":"J. Headache Pain"},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0023","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/07067437231209650","article-title":"Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study: le cannabidiol comme traitement d'appoint de la depression bipolaire aigue: une etude pilote","volume":"69","author":"Pinto","year":"2024","journal-title":"Can. J. Psychiatry"},{"issue":"11-B(E)","key":"10.1016\/j.psychres.2026.117380_bib0111","article-title":"The therapeutic potential of cannabis compared to benzodiazepines in the treatment of anxiety","volume":"80","author":"Piumatti","year":"2019","journal-title":"Diss. Abstr. Int.: B: Sci. Eng."},{"issue":"3","key":"10.1016\/j.psychres.2026.117380_bib0112","first-page":"e102","article-title":"Medical cannabis in patients with chronic pain: effect on pain relief, pain disability, and psychological aspects. a prospective non randomized single arm clinical trial","volume":"169","author":"Poli","year":"2018","journal-title":"Clin. Ter."},{"issue":"Supplement 1","key":"10.1016\/j.psychres.2026.117380_bib0113","first-page":"101","article-title":"Effects of cannabis based drugs on chronic neuropathic pain: comparison between italian and dutch medical cannabis variety","volume":"18","author":"Poli","year":"2018","journal-title":"Pain Pr."},{"issue":"5","key":"10.1016\/j.psychres.2026.117380_bib0161","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jpain.2012.01.003","article-title":"Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial","volume":"13","author":"Portenoy","year":"2012","journal-title":"J Pain"},{"key":"10.1016\/j.psychres.2026.117380_bib0011","series-title":"RStudio: Integrated Development Environment for R","year":"2025"},{"key":"10.1016\/j.psychres.2026.117380_bib0008","article-title":"Introduction to the GRADE tool for rating certainty in evidence and recommendations","volume":"25","author":"Prasad","year":"2024","journal-title":"Clin. Epidemiol. Glob. Health"},{"issue":"13","key":"10.1016\/j.psychres.2026.117380_bib0199","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1080\/10826084.2022.2107673","article-title":"Medical cannabis patients report improvements in health functioning and reductions in opiate use","volume":"57","author":"Pritchett","year":"2022","journal-title":"Subst. Use Misuse"},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0114","doi-asserted-by":"crossref","DOI":"10.1186\/s42238-021-00078-w","article-title":"Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic","volume":"3","author":"Rapin","year":"2021","journal-title":"J. cannabis res."},{"issue":"8","key":"10.1016\/j.psychres.2026.117380_bib0115","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00213-023-06399-3","article-title":"Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK medical cannabis registry","volume":"240","author":"Rifkin-Zybutz","year":"2023","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.psychres.2026.117380_bib0044","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b","article-title":"Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis","volume":"65","author":"Rog","year":"2005","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.psychres.2026.117380_bib0116","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1093\/pm\/pnab257","article-title":"First-year trajectories of medical cannabis use among adults taking opioids for chronic pain: an observational cohort study","volume":"22","author":"Ross","year":"2021","journal-title":"Pain Med."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0162","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1186\/s12889-020-09089-3","article-title":"Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis","volume":"20","author":"Round","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.psychres.2026.117380_bib0117","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114573","article-title":"Medical cannabis use in Canada and its impact on anxiety and depression: a retrospective study","volume":"313","author":"Sachedina","year":"2022","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.psychres.2026.117380_bib0118","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1017\/S1355617721000114","article-title":"An observational, longitudinal study of cognition in medical cannabis patients over the course of 12 months of treatment: preliminary results","volume":"27","author":"Sagar","year":"2021","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0119","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000493567","article-title":"Medical cannabis use by hodgkin lymphoma patients: experience of a single center","volume":"140","author":"Sarid","year":"2018","journal-title":"Acta Haematol."},{"issue":"6","key":"10.1016\/j.psychres.2026.117380_bib0120","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1089\/can.2019.0096","article-title":"A cross-sectional and prospective comparison of medicinal cannabis users and controls on self-reported health","volume":"6","author":"Schlienz","year":"2021","journal-title":"Cannabis Cannabinoid Res."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0121","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ijpp\/riac073","article-title":"Medicinal cannabis for patients with chronic non-cancer pain: analysis of safety and concomitant medications","volume":"31","author":"Schubert","year":"2023","journal-title":"Int. J. Pharm. Pr."},{"key":"10.1016\/j.psychres.2026.117380_bib0163","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsat.2017.03.012","article-title":"Medical cannabis use among patients with chronic pain in an interdisciplinary pain rehabilitation program: characterization and treatment outcomes","volume":"77","author":"Shah","year":"2017","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.psychres.2026.117380_bib0122","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/18-041","article-title":"Cannabidiol in anxiety and sleep: a large case series","volume":"23","author":"Shannon","year":"2019","journal-title":"Perm. J."},{"issue":"2","key":"10.1016\/j.psychres.2026.117380_bib0024","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpain.2007.09.002","article-title":"Nabilone for the treatment of pain in fibromyalgia","volume":"9","author":"Skrabek","year":"2008","journal-title":"J. Pain"},{"key":"10.1016\/j.psychres.2026.117380_bib0215","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1346207","article-title":"Cannabis use and mood disorders: a systematic review","volume":"12","author":"Sorkhou","year":"2024","journal-title":"Front Public Health"},{"issue":"7","key":"10.1016\/j.psychres.2026.117380_bib0123","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/acr.24985","article-title":"Predictors of pain reduction among fibromyalgia patients using medical cannabis: a long-term prospective cohort study","volume":"75","author":"Sotoodeh","year":"2023","journal-title":"Arthritis care res."},{"issue":"2","key":"10.1016\/j.psychres.2026.117380_bib0164","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/a-2215-6114","article-title":"Effectiveness of medical cannabis for the treatment of depression: a naturalistic outpatient study","volume":"57","author":"Specka","year":"2024","journal-title":"Pharmacopsychiatry"},{"issue":"9","key":"10.1016\/j.psychres.2026.117380_bib0006","article-title":"Pharmacotherapies for cannabis use disorder","volume":"9","author":"Spiga","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0124","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/15360288.2024.2414073","article-title":"Comparison of cannabis-based medicinal product formulations for fibromyalgia: a cohort study","volume":"39","author":"Sridharan","year":"2025","journal-title":"J. Pain Palliat. Care Pharmacother."},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/87551225231180796","article-title":"The effectiveness and adverse events of cannabidiol and tetrahydrocannabinol used in the treatment of anxiety disorders in a PTSD subpopulation: an interim analysis of an observational study","volume":"39","author":"Stack","year":"2023","journal-title":"J. Pharm. Technol."},{"key":"10.1016\/j.psychres.2026.117380_bib0045","article-title":"A double-blind, randomized, placebo-controlled test of the effects of cannabidiol on experiences of test anxiety among college students","author":"Stanley","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"issue":"6","key":"10.1016\/j.psychres.2026.117380_bib0205","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/ajad.13323","article-title":"Tobacco\/nicotine use among individuals using cannabis for therapeutic purposes","volume":"31","author":"Steinberg","year":"2022","journal-title":"Am. J. Addctn."},{"key":"10.1016\/j.psychres.2026.117380_bib0014","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2026.117380_bib0013","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0126","first-page":"125","article-title":"Medical cannabis prescription practices and quality of life in thai patients: a nationwide prospective observational cohort study","volume":"7","author":"Stienrut","year":"2024","journal-title":"Med. Cannabis Cannabinoids"},{"issue":"AUG","key":"10.1016\/j.psychres.2026.117380_bib0127","article-title":"Patient-reported symptom relief following medical cannabis consumption","volume":"9","author":"Stith","year":"2018","journal-title":"Front. pharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0128","doi-asserted-by":"crossref","DOI":"10.1186\/s42238-020-00051-z","article-title":"The effectiveness of inhaled Cannabis flower for the treatment of agitation\/irritability, anxiety, and common stress","volume":"2","author":"Stith","year":"2020","journal-title":"J. cannabis res."},{"key":"10.1016\/j.psychres.2026.117380_bib0129","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1135453","article-title":"Understanding feeling \"high\" and its role in medical cannabis patient outcomes","volume":"14","author":"Stith","year":"2023","journal-title":"Front. pharmacol."},{"key":"10.1016\/j.psychres.2026.117380_bib0196","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2022.102632","article-title":"Posttraumatic stress disorder, sleep and medical cannabis treatment: a daily diary study","volume":"92","author":"Sznitman","year":"2022","journal-title":"J. Anxiety Disord."},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/14737175.2023.2195551","article-title":"Clinical outcome data of chronic pain patients treated with cannabis-based oils and dried flower from the UK medical cannabis registry","volume":"23","author":"Tait","year":"2023","journal-title":"Expert Rev. Neurother."},{"issue":"9","key":"10.1016\/j.psychres.2026.117380_bib0131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290549","article-title":"Health-related quality of life in patients accessing medicinal cannabis in Australia: the QUEST initiative results of a 3-month follow-up observational study","volume":"18","author":"Tait","year":"2023","journal-title":"PLoS ONE [Electronic Resour."},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0132","article-title":"Improvements in health-related quality of life are maintained long-term in patients prescribed medicinal cannabis in Australia: the QUEST Initiative 12-month follow-up observational study","volume":"20","author":"Tait","year":"2025","journal-title":"PLoS ONE [Electronic Resour."},{"key":"10.1016\/j.psychres.2026.117380_bib0133","article-title":"Cannabis use and sleep quality in daily life: a daily diary study of adults starting cannabis for health concerns","volume":"21","author":"Tervo-Clemmens","year":"2022","journal-title":"medRxiv"},{"issue":"10","key":"10.1016\/j.psychres.2026.117380_bib0016","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.pain.2012.06.024","article-title":"An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain","volume":"153","author":"Toth","year":"2012","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190768","article-title":"Nabiximols combined with motivational enhancement\/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial","volume":"13","author":"Trigo","year":"2018","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1016\/j.psychres.2026.117380_bib0165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s40266-021-00913-y","article-title":"Medical cannabis use among older adults in Canada: self-reported data on types and amount used, and perceived effects","volume":"39","author":"Tumati","year":"2022","journal-title":"Drugs Aging"},{"issue":"9","key":"10.1016\/j.psychres.2026.117380_bib0166","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.clinthera.2017.01.016","article-title":"Effects on spasticity and neuropathic pain of an oral formulation of \u03949-tetrahydrocannabinol in patients with progressive multiple sclerosis","volume":"40","author":"van Amerongen","year":"2018","journal-title":"Clin. Ther."},{"issue":"11","key":"10.1016\/j.psychres.2026.117380_bib0134","article-title":"A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years","volume":"17","author":"Vickery","year":"2022","journal-title":"PLoS ONE [Electronic Resour."},{"issue":"11","key":"10.1016\/j.psychres.2026.117380_bib0202","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187795","article-title":"Associations between medical cannabis and prescription opioid use in chronic pain patients: a preliminary cohort study","volume":"12","author":"Vigil","year":"2017","journal-title":"PLoS ONE [Electronic Resour."},{"issue":"2","key":"10.1016\/j.psychres.2026.117380_bib0135","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3410","article-title":"UK medical cannabis registry: assessment of clinical outcomes in patients with insomnia","volume":"14","author":"Vivek","year":"2024","journal-title":"Brain Behav."},{"key":"10.1016\/j.psychres.2026.117380_bib0207","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107756","article-title":"Is cannabis use associated with tobacco cessation outcome? An observational cohort study in primary care","volume":"206","author":"Voci","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.psychres.2026.117380_bib0218","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/wps.21073","article-title":"Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention","volume":"22","author":"Volkow","year":"2023","journal-title":"World Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2026.117380_bib0141","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","article-title":"Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients","volume":"10","author":"Wade","year":"2004","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.psychres.2026.117380_bib0136","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2018.11.009","article-title":"Use of marijuana exclusively for medical purposes","volume":"195","author":"Wall","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.psychres.2026.117380_bib0137","first-page":"127","article-title":"Health outcomes among adults initiating medical marijuana for chronic pain: Preliminary findings from a 12-month prospective study","volume":"4","author":"Wang","year":"2021","journal-title":"Med. cannabis cannabinoids"},{"issue":"14","key":"10.1016\/j.psychres.2026.117380_bib0037","doi-asserted-by":"crossref","first-page":"E694","DOI":"10.1503\/cmaj.091414","article-title":"Smoked cannabis for chronic neuropathic pain: a randomized controlled trial","volume":"182","author":"Ware","year":"2010","journal-title":"Can. Med. Assoc. J."},{"issue":"12","key":"10.1016\/j.psychres.2026.117380_bib0167","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jpain.2015.07.014","article-title":"Cannabis for the management of pain: assessment of safety study (COMPASS)","volume":"16","author":"Ware","year":"2015","journal-title":"J. Pain"},{"issue":"12","key":"10.1016\/j.psychres.2026.117380_bib0138","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/14737175.2024.2423634","article-title":"UK medical cannabis registry: a cohort study of patients prescribed cannabis-based oils and dried flower for generalised anxiety disorder","volume":"24","author":"Warner-Levy","year":"2024","journal-title":"Expert Rev. Neurother."},{"issue":"1","key":"10.1016\/j.psychres.2026.117380_bib0139","article-title":"Tetrahydrocannabinol (Delta 9-THC) treatment in chronic central neuropathic pain and fibromyalgia patients: results of a multicenter survey","volume":"2009","author":"Weber","year":"2009","journal-title":"Anesth. Res. Pr."},{"issue":"10","key":"10.1016\/j.psychres.2026.117380_bib0038","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2009.200642","article-title":"Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial","volume":"81","author":"Weber","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117380_bib0015","unstructured":"Wells G, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2012."},{"issue":"6","key":"10.1016\/j.psychres.2026.117380_bib0168","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jpain.2007.12.010","article-title":"A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain","volume":"9","author":"Wilsey","year":"2008","journal-title":"J. Pain"},{"issue":"2","key":"10.1016\/j.psychres.2026.117380_bib0169","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpain.2012.10.009","article-title":"Low-dose vaporized cannabis significantly improves neuropathic pain","volume":"14","author":"Wilsey","year":"2013","journal-title":"J. Pain"},{"issue":"1 Supplement","key":"10.1016\/j.psychres.2026.117380_bib0140","first-page":"55","article-title":"Comparison of cannabis-based medicinal product formulations for chronic pain: a cohort study","volume":"17","author":"Yang","year":"2023","journal-title":"Br. J. Pain"},{"issue":"9395","key":"10.1016\/j.psychres.2026.117380_bib0170","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(03)14738-1","article-title":"Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial","volume":"362","author":"Zajicek","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.psychres.2026.117380_bib0171","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/10550887.2021.1956673","article-title":"Risk and benefit of cannabis prescription for chronic non-cancer pain","volume":"40","author":"Zloczower","year":"2022","journal-title":"J. Addictive Dis."},{"issue":"7","key":"10.1016\/j.psychres.2026.117380_bib0180","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1177\/07067437211060597","article-title":"Substance use disorders and psychoactive drug poisoning in medically authorized cannabis patients: longitudinal cohort study","volume":"67","author":"Zongo","year":"2022","journal-title":"Can. J. Psychiatry - Rev. Can. Psychiatr."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126004403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126004403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:24:33Z","timestamp":1788812673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178126004403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":219,"alternative-id":["S0165178126004403"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117380","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabis and cannabinoids for the treatment of mental and substance use disorders and symptoms: A systematic review and meta-analysis of experimental and observational studies","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117380"}}